(Q42165413)

17 October 2017

title

Fortum stability in different disposable infusion devices by pyridine assay (English)

1 reference

17 October 2017

1 reference

Favetta P

1

1 reference

17 October 2017

Allombert C

2

1 reference

17 October 2017

Breysse C

3

1 reference

17 October 2017

Dufresne C

4

1 reference

17 October 2017

Guitton J

5

1 reference

17 October 2017

Bureau J

6

1 reference

17 October 2017

publication date

1 March 2002

1 reference

Journal of Pharmaceutical and Biomedical Analysis

17 October 2017

published in

1 reference

17 October 2017

volume

27

1 reference

17 October 2017

issue

6

1 reference

17 October 2017

page(s)

873-879

1 reference

Pharmacokinetic-pharmacodynamic modeling of activity of ceftazidime during continuous and intermittent infusion.

17 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2801%2900588-X

7 January 2021

Continuous infusion of ceftazidime in cystic fibrosis patients during home treatment: clinical outcome, microbiology and pharmacokinetics

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2801%2900588-X

7 January 2021

Continuous infusion of beta-lactam antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2801%2900588-X

7 January 2021

Ceftazidime degradation rates for predicting stability in a portable infusion-pump reservoir

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2801%2900588-X

7 January 2021

Analysis of ceftazidime and related compounds by micellar electrokinetic chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2801%2900588-X

7 January 2021

Influence of pH, temperature, and buffers on the kinetics of ceftazidime degradation in aqueous solutions.

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2801%2900588-X

7 January 2021

A kinetic oxymoron: concentration-dependent first-order rate constants for hydrolysis of ceftazidime

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2801%2900588-X

7 January 2021

Stability of various antibiotics kept in an insulated pouch during administration via portable infusion pump

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2801%2900588-X

7 January 2021

Stability of ceftazidime (with arginine) in an elastomeric infusion device

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2801%2900588-X

7 January 2021

Stability of reconstituted solutions of ceftazidime for injections: an HPLC and CE approach

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2801%2900588-X

7 January 2021

Drug stability and pyridine generation in ceftazidime injection stored in an elastomeric infusion device

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2801%2900588-X

7 January 2021

Stability of ceftazidime in a viscous eye drop formulation

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2801%2900588-X

7 January 2021

Simultaneous Quantification of Ceftazidime and Pyridine, its Main Degradation Product, by High-Performance Liquid Chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2801%2900588-X

7 January 2021

10.1016/S0731-7085(01)00588-X

Identifiers

DOI

1 reference

17 October 2017

1 reference